ADAMTS7 and hypertensive disorder: By using linear regression adjusted for bleeding, age, gender, hypertension, DOAC dose and renal function, we found that bleeding was significantly associated with ADAMTS7 promoter demethylation (β −3.125, 95% C.I. −6.208, −0.042, p = 0.047).